NERVGEN PHARMA CORP. Diluted EPS

by

Quick Answer

NERVGEN PHARMA CORP. reported diluted eps of C$-0.61 per share for fiscal year 2025 (IFRS, Form 20-F).

Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.

NERVGEN PHARMA CORP. Diluted EPS — Annual History

Fiscal Year Diluted EPS YoY Change
2025 -C$0.61 -69.4%
2024 -C$0.36 —
  • NERVGEN PHARMA CORP.’s diluted eps fell 69.4% year over year.
  • The most recent figure is from NERVGEN PHARMA CORP.’s fiscal year 2025 annual report (Form 20-F), filed March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.

Last verified:

Leave a Comment